All In MedTech

Device Trial Radar · NCT03868462

Optos P200TE Agreement and Precision Study

Last checked: Nov 20, 2026Latest source record: Oct 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

137

Actual

Start

Feb 11, 2019

Primary completion

Sep 16, 2019

Study completion Sep 16, 2019

Sponsor

Lead sponsor
Optos, PLCNot on our public-company list
Sponsor type
Industry
First posted
Mar 11, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a prospective comparative, randomized, single center study to assess agreement and precision of the Optos P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.

Conditions

  • Retinal Disease
  • Glaucoma

Interventions

  • Optos P200TEDevice

    The P200TE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device.

  • Predicate DeviceDevice

    The predicate device is an optical coherence tomography system intended for in vivo imaging, axial cross-sectional, three-dimensional imaging and measurement of anterior and posterior ocular structures.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Limit of Agreement (LOA) between the Optos P200TE and predicate device measurements of full retinal thickness (μm).Time frame: At the end of Visit 1 or optional Visit 2 (each visit is 1 day)
  2. Limit of Agreement (LOA) between the Optos P200TE and predicate device measurements of retinal nerve fiber layer thickness (μm).Time frame: At the end of Visit 1 or optional Visit 2 (each visit is 1 day)
  3. Limit of Agreement (LOA) between the Optos P200TE and predicate device measurements of ganglion cell complex thickness (μm).Time frame: At the end of Visit 1 or optional Visit 2 (each visit is 1 day)

8 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • New England Retina Consultants

    Springfield, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.